SCHEMBL14005309

SCHEMBL14005309

CC(C)(C)OC(=O)N(CCOc1cncc(C(C)(C)C)c1)Cc1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SLC2A4 P14672 2/20 0.38
SLC2A8 Q9NY64 1/20 0.38
SLC2A1 P11166 3/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
KCNQ4 P56696 1/20 0.36
KCNQ5 Q9NR82 1/20 0.36
GRM2 Q14416 1/20 0.36
ROCK2 O75116 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
F2 P00734 2/20 0.35
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
ROCK1 Q13464 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14004843 0.90 KDM4E (0.42) LMNASLC2A1KDM4EALDH1A1F2
SCHEMBL14030942 0.88 SLC2A4 (0.40) SSTR4SLC2A4SLC2A8SLC2A1KCNQ4
SCHEMBL4743598 0.85 SLC2A4 (0.40) SSTR4SLC2A4SLC2A8SLC2A1KCNQ4
SCHEMBL14004845 0.83 CHRNB2 (0.36) SSTR4F2
SCHEMBL5153408 0.79 HDAC3 (0.46) LMNASMN1; SMN2KDM4EALDH1A1HDAC3
SCHEMBL6508209 0.78 SSTR4 (0.44) SSTR4LMNASMN1; SMN2SLC2A4SLC2A8
SCHEMBL7497944 0.75 SSTR4 (0.40) SSTR4TP53MAPTKCNQ4KCNQ5
SCHEMBL4744310 0.74 SSTR4 (0.56) SSTR4LMNATP53MAPTKCNQ4
SCHEMBL3899039 0.74 SSTR4 (0.47) SSTR4LMNASMN1; SMN2TP53MAPT
SCHEMBL2259362 0.73 ROCK1 (0.48) SSTR4TP53MAPTKCNQ4KCNQ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293712-A1 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof WYETH (US) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293712-A1 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof PDPK1, PDK2, PDK3 SSTR4 3719/4885LMNA 1422/4885SMN1; SMN2 2665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.